ClinConnect ClinConnect Logo
Search / Trial NCT06315179

Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation (STRIDE)

Launched by SEATTLE CHILDREN'S HOSPITAL · Mar 11, 2024

Trial Information

Current as of July 23, 2025

Recruiting

Keywords

Ibd Dgbi

ClinConnect Summary

The Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation (STRIDE) trial is studying how gut inflammation affects children with inflammatory bowel diseases, such as Crohn's Disease and Ulcerative Colitis. This research will also include a group of children who have issues with gut-brain interactions but do not have visible gut inflammation. The goal is to gather important long-term information and samples from these patients to better understand their conditions.

To be eligible for the study, participants should be children suspected of having Crohn's Disease, Ulcerative Colitis, or Indeterminate Colitis. However, they must not have other serious health problems, be pregnant, or have issues with substance abuse. Participants in this study can expect to provide clinical data and samples that will help researchers learn more about these diseases and potentially improve future treatments. If you or your child is interested, this could be a chance to contribute to important medical research.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Suspected diagnosis of CD (Crohn's Disease), UC (Ulcerative Colitis) or Indeterminate colitis (IC)
  • Exclusion Criteria:
  • * Evidence of Other Complicating Medical Issues:
  • Other serious medical conditions, such as neurological, liver, kidney, or systemic disease
  • Pregnancy
  • Tobacco, alcohol, or illicit drug abuse

About Seattle Children's Hospital

Seattle Children's Hospital is a leading pediatric healthcare institution dedicated to advancing the health and well-being of children through innovative clinical research and trials. As a prominent sponsor of clinical studies, the hospital focuses on developing new treatments and therapies that address the unique medical needs of children. With a commitment to excellence, Seattle Children's Hospital collaborates with a network of researchers, healthcare professionals, and academic institutions to ensure rigorous scientific standards and ethical practices in all its clinical investigations. By prioritizing patient safety and scientific integrity, the hospital aims to contribute to the global body of knowledge in pediatric medicine and improve outcomes for children with various health conditions.

Locations

Seattle, Washington, United States

Patients applied

0 patients applied

Trial Officials

Betty (Hengqi) Zheng, MD

Principal Investigator

Seattle Children's Hospital, University of Washington

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported